Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir Reply

被引：0
|
作者：
Gordon, Stuart C. [1 ]
Yee, Leland J. [2 ]
Martins, Eduardo Bruno [2 ]
机构：
[1] Henry Ford Hosp, Detroit, MI 48202 USA
[2] Gilead Sci, Foster City, CA USA
来源：
HEPATOLOGY | 2014年 / 59卷 / 06期
关键词：
D O I：
10.1002/hep.26902
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2427 / 2427
页数：1
相关论文
共 50 条
  • [11] Does elevation of serum creatinine in patients with chronic hepatitis C under therapy of telaprevir mean renal impairment?
    Matsui, Katsuomi
    Kamijo-Ikemori, Atsuko
    Sugaya, Takeshi
    Ikeda, Hiroki
    Okuse, Chiaki
    Shibagaki, Yugo
    Yasuda, Takashi
    Kimura, Kenjiro
    NEPHROLOGY, 2015, 20 (11) : 843 - 848
  • [12] Reply to: Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C
    Sakin, Yusuf Serdar
    Polat, Zulfikar
    Demirci, Hakan
    Kekilli, Murat
    Uygun, Ahmet
    Bagci, Sait
    HEPATOLOGY RESEARCH, 2014, 44 (09) : 1037 - 1037
  • [13] Effect of telaprevir-based triple therapy on the renal function of chronic hepatitis C patients
    Ozeki, Itaru
    Nakzima, Tomoaki
    Hige, Shuhei
    Karino, Yoshiyasu
    HEPATOLOGY, 2012, 56 : 1040A - 1040A
  • [14] Telaprevir triple therapy in multimorbid chronic hepatitis C genotype 1 patients under hemodialysis
    Wiegand, Johannes
    Maasoumy, Benjamin
    Buggisch, Peter
    Buslau, Anna
    Schiefke, Ingolf
    Berg, Thomas
    Wedemeyer, Heiner
    Sarrazin, Christoph
    Hinrichsen, Holger
    HEPATOLOGY, 2013, 58 : 1112A - 1113A
  • [15] TELAPREVIR OR BOCEPREVIR THERAPY IN CHRONIC HEPATITIS C PATIENTS WITH END STAGE RENAL DISEASE ON HEMODIALYSIS IS SAFE, TOLERABLE AND FEASIBLE
    Sclair, S.
    Patel, A.
    Junaidi, O.
    Copado, V.
    Martin, P.
    Rudraraju, M.
    Bhamidimarri, K. R.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S370 - S371
  • [16] Adverse Outcomes of Telaprevir versus Boceprevir Antiviral Therapy in Chronic Hepatitis C Cirrhotic Patients
    Mousa, Omar
    Pham, Ly-Elaine
    Maldonado, Stephanie
    Egwim, Chukwuma
    Zela, Scott
    Ankoma-Sey, Victor
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S498 - S499
  • [17] Review of boceprevir and telaprevir for the treatment of chronic hepatitis C
    Wilby, Kyle J.
    Partovi, Nilufar
    Ford, Jo-Ann E.
    Greanya, Erica D.
    Yoshida, Eric M.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (04) : 205 - 210
  • [18] Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting
    Jennifer C. Price
    Rosemary C. Murphy
    Valentina A. Shvachko
    Mary Pat Pauly
    M. Michele Manos
    Digestive Diseases and Sciences, 2014, 59 : 3043 - 3052
  • [19] SAFETY OF TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR IN HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE - PREDICTIVE FACTORS FOR SEPSIS
    Rutter, K.
    Ferlitsch, A.
    Maieron, A.
    Staettermayer, A. F.
    Graziadei, I.
    Dulic, M.
    Gschwantler, M.
    Stauber, R.
    Hofer, H.
    Peck-Radosavljevic, M.
    Vogel, W.
    Trauner, M.
    Ferenci, P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S30 - S30
  • [20] Incidence, management and costs of adverse effects in chronic hepatitis C patients on triple therapy with telaprevir or boceprevir: First 12 weeks of treatment
    Guglieri-Lopez, Beatriz
    Manuel Ventura-Cerda, Jose
    Gomez-Alvarez, Sandra
    Climente-Marti, Monica
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (05): : 331 - 336
12345